Reviewed,
UniProtKB/Swiss-Prot Q8NER1 (TRPV1_HUMAN)
Last modified
July 7, 2009.
Version 57.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Transient receptor potential cation channel subfamily V member 1 Short name=TrpV1 Alternative name(s): Osm-9-like TRP channel 1 Short name=OTRPC1 Vanilloid receptor 1 Capsaicin receptor | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 839 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Receptor-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. May be involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Ref.1 Ref.2 Ref.3 |
| Enzyme regulation | Channel activity is activated via the interaction with PIRT and phosphatidylinositol-4,5-bisphosphate (PIP2). Both PIRT and PIP2 are required to activate channel activity By similarity. |
| Subunit structure | Self-associates. Probably homotetramer. May also form a heteromeric channel with TRPV3. Interacts with calmodulin, PIRT, PRKCM and CSK. Interacts with PRKCG and NTRK1, probably by forming a trimeric complex By similarity. |
| Subcellular location | Cell membrane; Multi-pass membrane protein By similarity. |
| Tissue specificity | Widely expressed at low levels. Expression is elevated in dorsal root ganglia. In skin, expressed in cutaneous sensory nerve fibers, mast cells, epidermal keratinocytes, dermal blood vessels, the inner root sheet and the infundibulum of hair follicles, differentiated sebocytes, sweat gland ducts, and the secretory portion of eccrine sweat glands (at protein level). Ref.1 Ref.2 Ref.7 |
| Domain | The association domain (AD) is necessary for self-association By similarity. |
| Post-translational modification | Phosphorylation by PKA reverses capsaicin-induced dephosphorylation at multiple sites, probably including Ser-117 as a major phosphorylation site. Phoshphorylation by CAMKII seems to regulate binding to vanilloids. Phosphorylated and modulated by PKCM and probably PKCZ. Dephosphorylation by calcineurin seems to lead to receptor desensitization and phosphorylation by CAMKII recovers activity By similarity. |
| Miscellaneous | Responses evoked by low pH and heat, and capsaicin can be antagonized by capsazepine. |
| Sequence similarities | Belongs to the transient receptor family. TrpV subfamily. Contains 6 ANK repeats. |
| Sequence caution | The sequence AAG43467.1 differs from that shown. Reason: Frameshift at position 498. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 839 | 839 | Transient receptor potential cation channel subfamily V member 1 | PRO_0000215338 | |||||
Regions | |||||||||
| Topological domain | 1 – 433 | 433 | Cytoplasmic Potential | ||||||
| Transmembrane | 434 – 454 | 21 | Potential | ||||||
| Topological domain | 455 – 476 | 22 | Extracellular Potential | ||||||
| Transmembrane | 477 – 497 | 21 | Potential | ||||||
| Topological domain | 498 – 513 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 514 – 534 | 21 | Potential | ||||||
| Topological domain | 535 | 1 | Extracellular Potential | ||||||
| Transmembrane | 536 – 556 | 21 | Potential | ||||||
| Topological domain | 557 – 579 | 23 | Cytoplasmic Potential | ||||||
| Transmembrane | 580 – 600 | 21 | Potential | ||||||
| Topological domain | 601 – 659 | 59 | Pore forming Probable | ||||||
| Transmembrane | 660 – 680 | 21 | Potential | ||||||
| Topological domain | 681 – 839 | 159 | Cytoplasmic Potential | ||||||
| Repeat | 111 – 153 | 43 | ANK 1 | ||||||
| Repeat | 154 – 200 | 47 | ANK 2 | ||||||
| Repeat | 201 – 247 | 47 | ANK 3 | ||||||
| Repeat | 248 – 283 | 36 | ANK 4 | ||||||
| Repeat | 284 – 332 | 49 | ANK 5 | ||||||
| Repeat | 333 – 359 | 27 | ANK 6 | ||||||
| Region | 685 – 713 | 29 | AD By similarity | ||||||
| Region | 768 – 802 | 35 | Interaction with calmodulin By similarity | ||||||
| Region | 778 – 793 | 16 | Required for PIP2-mediated channel inhibition By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 117 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 145 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 371 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 502 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 705 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 775 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 801 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 821 | 1 | Phosphoserine By similarity | ||||||
| Glycosylation | 604 | 1 | N-linked (GlcNAc...) By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 91 | 1 | P → S: dbSNP rs222749. | VAR_057307 | |||||
| Natural variant | 469 | 1 | T → I: dbSNP rs224534. | VAR_057308 | |||||
| Natural variant | 505 | 1 | T → A: dbSNP rs17633288. | VAR_057309 | |||||
| Natural variant | 585 | 1 | I → V Ref.1 | VAR_022246 | |||||
Experimental info | |||||||||
| Mutagenesis | 511 | 1 | Y → A: Loss of sensitivity to capsaicin. Ref.8 | ||||||
| Mutagenesis | 550 | 1 | T → I: Reduces sensitivity to capsaicin 40-fold. Ref.8 | ||||||
| Sequence conflict | 315 | 1 | I → M in AAG43466. Ref.2 | ||||||
| Sequence conflict | 336 | 1 | T → M in CAB89866. Ref.3 | ||||||
Sequences
| ||||||||||||||||||
References
Cross-references
Sequence databases | |
|---|---|
| AJ277028 mRNA. Translation: CAB95729.1. AF196175 mRNA. Translation: AAG43466.1. AF196176 mRNA. Translation: AAG43467.1. Frameshift. AJ272063 mRNA. Translation: CAB89866.2. AY131289 mRNA. Translation: AAM89472.1. AL136801 mRNA. Translation: CAB66735.1. | |
| IPI | IPI00874241. |
| PIR | JC7621. |
| RefSeq | NP_061197.4. NP_542435.2. NP_542436.2. NP_542437.2. |
| UniGene | Hs.579217 Hs.655380 |
3D structure databases | |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | Q8NER1. |
Proteomic databases | |
| PRIDE | Q8NER1. |
Genome annotation databases | |
| Ensembl | ENSG00000196689. Homo sapiens. [Contig view] |
| GeneID | 7442. |
| KEGG | hsa:7442. |
Organism-specific databases | |
| GeneCards | GC17M003415. |
| H-InvDB | HIX0013428. HIX0079948. |
| HGNC | HGNC:12716. TRPV1. |
| MIM | 602076. gene. |
| PharmGKB | PA37329. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q8NER1. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | pi3kplctrkpathway. Trk receptor signaling mediated by PI3K and PLC-gamma. mapktrkpathway. Trk receptor signaling mediated by the MAPK pathway. |
Gene expression databases | |
| ArrayExpress | Q8NER1. |
| Bgee | Q8NER1. |
| CleanEx | HS_TRPV1. |
| GermOnline | ENSG00000196689. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR002110. ANK. IPR005821. Ion_trans. IPR004729. TRP_channel. IPR008347. Vanilpoid_rcpt. [Graphical view] |
| Gene3D | G3DSA:1.25.40.20. ANK. 1 hit. |
| Pfam | PF00023. Ank. 3 hits. PF00520. Ion_trans. 1 hit. [Graphical view] |
| PRINTS | PR01768. TRPVRECEPTOR. |
| SMART | SM00248. ANK. 4 hits. [Graphical view] |
| TIGRFAMs | TIGR00870. trp. 1 hit. |
| PROSITE | PS50297. ANK_REP_REGION. 1 hit. PS50088. ANK_REPEAT. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| BindingDB | Q8NER1. |
| DrugBank | DB00132. Alpha-Linolenic Acid. DB00168. Aspartame. DB00159. Icosapent. |
| NextBio | 29140. |
| SOURCE | Search... |
Entry information
| Entry name | TRPV1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8NER1 Secondary accession number(s): Q9H0G9 Q9NY22 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


